Blood-based biomarkers of Alzheimer’s disease: Challenging but feasible

Laboratory of Personality & Cognition, Intramural Research Program, National Institue on Aging, NIH, USA.
Biomarkers in Medicine (Impact Factor: 2.86). 02/2010; 4(1):65-79. DOI: 10.2217/bmm.09.84
Source: PubMed

ABSTRACT Blood-based biomarkers present a considerable challenge: technically, as blood is a complex tissue and conceptually, as blood lacks direct contact with brain. Nonetheless, increasing evidence suggests that there is a blood protein signature, and possibly a transcript signature, that might act to increase confidence in diagnosis, be used to predict progression in either disease or prodromal states, and that may also be used to monitor disease progression. Evidence for this optimism comes partly from candidate protein studies, including those suggesting that amyloid-beta measures might have value in prediction and those studies of inflammatory markers that consistently show change in Alzheimer's disease, and partly from true proteomics studies that are beginning to identify markers in blood that replicate across studies and populations.

Download full-text


Available from: Simon Lovestone, May 19, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: An approach is proposed using cellular neural networks applied image processing, for the detection and characterisation of superficial faults in mechanical parts. There are above all two advantages deriving from an application of the proposed methodologies: the automization of a procedure, that of non-destructive tests (NDT), which is today carried out manually, and the possibility to reduce to a negligible amount the time spent on checking operations at present estimated to be in the order of a number of hours for each separate mechanical part
    Cellular Neural Networks and Their Applications, 2000. (CNNA 2000). Proceedings of the 2000 6th IEEE International Workshop on; 02/2000
  • Biomarkers in Medicine 02/2010; 4(1):1-2. · 2.86 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Neuroproteomics has become a 'symbol' or even a 'sign' for neuroscientists in the post-genomic era. During the last several decades, a number of proteomic approaches have been used widely to decipher the complexity of the brain, including the study of embryonic stages of human or non-human animal brain development. The use of proteomic techniques has allowed for great scientific advancements, including the quantitative analysis of proteomic data using 2D-DIGE, ICAT and iTRAQ. In addition, proteomic studies of the brain have expanded into fields such as subproteomics, synaptoproteomics, neural plasma membrane proteomics and even mitochondrial proteomics. The rapid progress that has been made in this field will not only increase the knowledge based on the neuroproteomics of the developing brain but also help to increase the understanding of human neurological diseases. This paper will focus on proteomic studies in the central nervous system and especially those conducted on the development of the brain in order to summarize the advances in this rapidly developing field.
    Neurochemical Research 10/2010; 35(10):1487-500. DOI:10.1007/s11064-010-0218-z · 2.55 Impact Factor
Show more